You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Testosterone Cypionate-estradiol Cypionate patents expire, and when can generic versions of Testosterone Cypionate-estradiol Cypionate launch?

Testosterone Cypionate-estradiol Cypionate is a drug marketed by Watson Labs and is included in one NDA.

The generic ingredient in TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE is estradiol cypionate; testosterone cypionate. There are seventy-five drug master file entries for this compound. Additional details are available on the estradiol cypionate; testosterone cypionate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE?
  • What are the global sales for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE?
  • What is Average Wholesale Price for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE?
Summary for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 2
DailyMed Link:TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE at DailyMed
Drug patent expirations by year for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE
Recent Clinical Trials for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
Sidney Kimmel Comprehensive Cancer CenterPhase 2
Baylor College of MedicinePhase 1

See all TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE clinical trials

US Patents and Regulatory Information for TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs TESTOSTERONE CYPIONATE-ESTRADIOL CYPIONATE estradiol cypionate; testosterone cypionate INJECTABLE;INJECTION 085603-001 Mar 13, 1986 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.